Lowering plasma homocysteine with folic acid in cardiovascular disease: what will the trials tell us?
Doshi
Sagar N
SN
Cardiovascular Institute, Mount Sinai School of Medicine, New York, USA.
Moat
Stuart J
SJ
McDowell
Ian F W
IF
Lewis
Malcolm J
MJ
Goodfellow
Jonathan
J
D002318:Cardiovascular Diseases / Q000097:blood / Q000188:drug therapy* / Q000517:prevention & control; D002986:Clinical Trials as Topic; D004730:Endothelium, Vascular / Q000187:drug effects; D005260:Female; D005492:Folic Acid / Q000008:administration & dosage*; D006710:Homocysteine / Q000097:blood* / Q000187:drug effects*; D006801:Humans; D008297:Male; D011379:Prognosis; D012680:Sensitivity and Specificity; D016896:Treatment Outcome
D006710:Homocysteine; D005492:Folic Acid